RIDAS OPTIC SRL
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 3
- Period
- 12 August 2026 – 28 September 2026
Its main clients
- SPITALUL JUDETEAN DE URGENTA RESITA · 1 contract
- SPITALUL CLINIC DE BOLI INFECTIOASE CLUJ · 1 contract
- SPITALUL CLINIC JUDETEAN DE URGENTA SF.SPIRIDON IASI · 1 contract
Where and what
Supplies · 3
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 17 August 2028 re-tender around February 2028 |
Medicamente 1/2026
SPITALUL CLINIC DE BOLI INFECTIOASE CLUJ framework agreement |
RIDAS OPTIC SRL COMPANIA NATIONALA UNIFARM BYA SELL ALLIANCE HEALTHCARE ROMANIA FRESENIUS KABI ROMANIA BIOEEL PHARM AHEAD S.R.L. DONA. LOGISTICA FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. ORIGIN PHARMA DISTRIBUTION NORD PHARMA S.R.L. PHARMA VISION PLUS ND PHARMA S.R.L. THREE PHARM Pharma FARMEXIM S.A. FITERMAN DISTRIBUTION B.BRAUN MEDICAL DR.MAX TRIDENT PHARMA FIDELIO FARM S.R.L. 7 bids received |
– |
| 7 September 2029 re-tender around March 2029 |
Acord cadru furnizare produse farmaceutice VI
SPITALUL JUDETEAN DE URGENTA RESITA framework agreement |
Pharma ALLIANCE HEALTHCARE ROMANIA DR.MAX FARMEXIM S.A. DONA. LOGISTICA BIOEEL THREE PHARM FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. COMPANIA NATIONALA UNIFARM YORK FARM FRESENIUS KABI ROMANIA TIS FARMACEUTIC B.BRAUN MEDICAL RIDAS OPTIC SRL 5 bids received |
– |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 28/09/2026 | Acord cadru furnizare produse farmaceutice VI | SPITALUL JUDETEAN DE URGENTA RESITA | – |
| 24/08/2026 | Medicamente 1/2026 | SPITALUL CLINIC DE BOLI INFECTIOASE CLUJ | – |
| 12/08/2026 | MEDICAMENTE | SPITALUL CLINIC JUDETEAN DE URGENTA SF.SPIRIDON IASI | – |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.